Heterogeneity in COVID-19 patient volume, characteristics and outcomes across US Department of Veterans Affairs facilities: an observational cohort study. Issue 3 (8th March 2021)

• Record Type: Journal Article
• Authors: Bravata, Dawn M; Myers, Laura J; Perkins, Anthony J; Keyhani, Salomeh; Zhang, Ying; Zillich, Alan J; Dysangco, Andrew; Lindsey, Reese; Sharmitha, Dev; Myers, Jennifer; Austin, Charles; Sexson, Ali; Arling, Greg
• Is Part Of: BMJ open. Volume 11:Issue 3(2021)
• Publication Date: 2021-03-08
• Subjects: COVID-19 -- adult intensive & critical care -- general medicine (see internal medicine); Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2020-044646
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Objective: Studies describe COVID-19 patient characteristics and outcomes across populations, but reports of variation across healthcare facilities are lacking. The objectives were to examine differences in COVID-19 patient volume and mortality across facilities, and understand whether facility variation in mortality was due primarily to differences in patient versus facility characteristics. Design: Observational cohort study with multilevel mixed effects logistic regression modelling. Setting: The Veterans Health Administration (VA) is the largest healthcare system in the USA. Participants: Patients with COVID-19. Main outcome: All-cause mortality within 45 days after COVID-19 testing (March–May, follow-up through 16 July 2020). Results: Among 13 510 patients with COVID-19, 3942 (29.2%) were admitted (2266/3942 (57.5%) ward; 1676/3942 (42.5%) intensive care unit (ICU)) and 679/3942 (17.2%) received mechanical ventilation. Marked heterogeneity was observed across facilities in median age (range: 34.3–83.9 years; facility mean: 64.7, SD 7.2 years); patient volume (range: 1–737 at 160 facilities; facility median: 48.5, IQR 14–105.5); hospital admissions (range: 1–286 at 133 facilities; facility median: 11, IQR 1–26.5); ICU caseload (range: 1–85 at 115 facilities; facility median: 4, IQR 0–12); and mechanical ventilation (range: 1–53 at 90 facilities; facility median: 1, IQR 0–5). Heterogeneity was also observed in facility mortality for all patients with COVID-19 (range: 0%–29.7%; facility median: 8.9%, IQR 2.4%–13.7%); inpatients (range: 0%–100%; facility median: 18.0%, IQR 5.6%–28.6%); ICU patients (range: 0%–100%; facility median: 28.6%, IQR 14.3%–50.0%); and mechanical ventilator patients (range: 0%–100%; facility median: 52.7%, IQR 33.3%–80.6%). The majority of variation in facility mortality was attributable to differences in patient characteristics (eg, age). Conclusions: Marked heterogeneity in COVID-19 patient volume, characteristics and mortality were observed across VA facilities nationwide. Differences in patient characteristics accounted for the majority of explained variation in mortality across sites. Variation in unadjusted COVID-19 mortality across facilities or nations should be considered with caution.